Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

RNC Pharma: Online Sales on Veterinary Market Double in January 2024

Thursday, March 7, 2024

In January 2024, 2.1 billion rubles’ worth of veterinary drugs were sold on the Russian veterinary retail market (retail prices, VAT included), up 11.8% from January 2023. In physical terms, 16.5 million minimum dosage units (MDU) were sold, up 7.6% from January 2023. This upward trend is strongly associated with the development of the online segment—the online sales of veterinary products went up 2 times in monetary and 1.7 times in physical terms against January 2023.

At the same time, the offline growth rates slowed down. In physical terms, the sales remained virtually the same, growing 0.13% from January 2023. In rubles, the offline sales fell 0.03%. As a result, the share of the online channel in the veterinary market grew steadily throughout 2023, reaching its highest in January 2024. In the analyzed period, the share of e-com was as high as 21% in monetary terms (against 11.6% in January 2023). In physical terms, the share grew from 10.4% in January 2023 to 16.4% in January 2024.

Despite the low season, insectoacaricidal Bravecto by MSD accounts for the largest online sales volume in monetary terms, 14.7% of the total online sales. The sales of the drugs grew 2.7 times against January 2023, meaning that consumers may already be stocking up on the product before the season begins. In January 2024, veterinary drugs by 148 companies were sold on the e-com market. The most popular drugs were American-made—American companies accounted for 43.5% of the sales (in rubles). Russian companies accounted for 26.2%, up 3.5% from January 2023.

As for the offline market, anthelmintic Milbemax by Elanco was the most popular drug—its sales went up 5.3% from January 2023. Veterinary drugs from 208 corporations were sold offline, with 51% of them Russian-made (in monetary terms).

Elanco had the largest sales volume in January 2024; the company’s sales grew 20.4% in rubles. Another American company, Zoetis, dropped to third place in the rankings—its sales fell 16% from January 2023. However, it is still the leader in the online channel, accounting for 18% of the market. KRKA (Slovenia) went up quite a few positions in the rankings; in January 2024, the company had the second largest sales volume in monetary terms. Offline sales accounted for the largest sales volume, although the company’s growth rates in e-com were several times higher.

Fig. Monthly growth rates of the Russian veterinary retail market (e-com included) in January 2022–January 2024 (billion RUB, retail prices, VAT included)